Attached files

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                Date of Earliest Event Reported: August 23, 2011


                              CREENERGY CORPORATION
                              ---------------------
             (Exact name of registrant as specified in its charter)


             Nevada                  333-133347                98-0479983
-----------------------------   --------------------  --------------------------
(State or other jurisdiction      (Commission File    (IRS Employer Identifica
    of incorporation)                 Number)                 -tion Number)


    601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
    -------------------------------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)


                                 (780) 668-7422
                                ----------------
               Registrant's telephone number, including area code

         Check the  appropriate  box below if the Form 8-K filing is intended to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))






                SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS

Item 1.01 Entry into a Material Definitive Agreement.

On August 23, 2011,  CREEnergy  Corporation ("the Company") entered into a Asset
Purchase with William Campbell and Scott McKinley to acquire  intangible  assets
and intellectual property known as the Peptide Technology Platform.

The Peptide Technology Platform includes the technology platforms for developing
a variety of drug candidates and biological  solutions for existing  problems in
humans, animals and the environment.

In exchange for such assets,  the Company  will issue  75,000,000  shares of its
restricted  common  stock to the owners of the  technology.  The  closing of the
transaction  is dependent  upon the  conclusion of due diligence by both parties
and the finalization of the agreement between both the Company and the owners of
the technology.








                                       2





                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.



                                        CREENERGY CORPORATION


                                        By: /s/ Shari Sookarookoff
                                            ------------------------------------
                                            Shari Sookarookoff, CEO


                                            Date: September 1, 2011